As­traZeneca's Alex­ion to take new R&D space in biotech tow­er in New Haven

A new biotech tow­er in New Haven, Con­necti­cut, has at­tract­ed sev­er­al well-known an­chor ten­ants.

Alex­ion Phar­ma­ceu­ti­cals, bought by phar­ma gi­ant As­traZeneca for $39 bil­lion last …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER